Robert J. Canter

7.3k total citations
201 papers, 4.5k citations indexed

About

Robert J. Canter is a scholar working on Oncology, Pulmonary and Respiratory Medicine and Immunology. According to data from OpenAlex, Robert J. Canter has authored 201 papers receiving a total of 4.5k indexed citations (citations by other indexed papers that have themselves been cited), including 97 papers in Oncology, 86 papers in Pulmonary and Respiratory Medicine and 48 papers in Immunology. Recurrent topics in Robert J. Canter's work include Sarcoma Diagnosis and Treatment (51 papers), Immune Cell Function and Interaction (35 papers) and Vascular Tumors and Angiosarcomas (25 papers). Robert J. Canter is often cited by papers focused on Sarcoma Diagnosis and Treatment (51 papers), Immune Cell Function and Interaction (35 papers) and Vascular Tumors and Angiosarcomas (25 papers). Robert J. Canter collaborates with scholars based in United States, United Kingdom and France. Robert J. Canter's co-authors include Richard J. Bold, William J. Murphy, Steve R. Martinez, Arta M. Monjazeb, Steven K. Grossenbacher, Robert D. Boutin, Sean J. Judge, Dariusz Borys, Leon Lenchik and Warren H. Tseng and has published in prestigious journals such as New England Journal of Medicine, Journal of Clinical Investigation and Journal of Clinical Oncology.

In The Last Decade

Robert J. Canter

192 papers receiving 4.5k citations

Author Peers

Peers are selected by citation overlap in the author's most active subfields. citations · hero ref

Author Last Decade Papers Cites
Robert J. Canter 2.1k 1.8k 1.0k 889 629 201 4.5k
Roberto Stasi 1.1k 0.6× 1.1k 0.6× 1.5k 1.5× 1.1k 1.2× 200 0.3× 161 9.7k
K. Scott Baker 920 0.4× 893 0.5× 765 0.8× 456 0.5× 327 0.5× 162 4.7k
Marc E. Horowitz 1.2k 0.6× 1.9k 1.1× 648 0.6× 789 0.9× 496 0.8× 98 5.9k
Dominique Farge 1.3k 0.6× 1.3k 0.8× 1.8k 1.8× 1.2k 1.4× 1.4k 2.2× 250 9.1k
Meenakshi Devidas 2.8k 1.4× 1.7k 1.0× 527 0.5× 712 0.8× 587 0.9× 311 12.6k
Celia M. Divino 2.0k 1.0× 1.4k 0.8× 2.3k 2.3× 3.4k 3.8× 652 1.0× 221 7.9k
Marc Riquet 2.5k 1.2× 4.2k 2.4× 329 0.3× 2.3k 2.6× 281 0.4× 337 6.8k
Peter Chang 781 0.4× 1.4k 0.8× 430 0.4× 1.0k 1.2× 200 0.3× 151 4.5k
Jan Paul de Boer 1.6k 0.8× 788 0.4× 599 0.6× 698 0.8× 359 0.6× 118 3.9k
Christina Peters 2.1k 1.0× 778 0.4× 1.2k 1.2× 450 0.5× 172 0.3× 242 8.2k

Countries citing papers authored by Robert J. Canter

Since Specialization
Citations

This map shows the geographic impact of Robert J. Canter's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Robert J. Canter with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Robert J. Canter more than expected).

Fields of papers citing papers by Robert J. Canter

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Robert J. Canter. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Robert J. Canter. The network helps show where Robert J. Canter may publish in the future.

Co-authorship network of co-authors of Robert J. Canter

This figure shows the co-authorship network connecting the top 25 collaborators of Robert J. Canter. A scholar is included among the top collaborators of Robert J. Canter based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Robert J. Canter. Robert J. Canter is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Kim, Jinhwan, et al.. (2025). Myeloid Cells in the Immunosuppressive Microenvironment as Immunotargets in Osteosarcoma. ImmunoTargets and Therapy. Volume 14. 247–258. 2 indexed citations
2.
Judge, Sean J., et al.. (2025). What’s in a name? Memory NK cells for cancer immunotherapy. Journal for ImmunoTherapy of Cancer. 13(1). e010850–e010850.
3.
Judge, Sean J., Arta M. Monjazeb, Steven W. Thorpe, et al.. (2024). Visceral fat area and subcutaneous fat area as measures of body composition in soft tissue sarcoma. Journal of Surgical Oncology. 130(3). 543–551.
4.
Chavez, Gilda, et al.. (2024). Musculoskeletal Tumor Society Member Survey: Intra‐Operative Peripheral Margins in Soft Tissue Sarcoma. Journal of Surgical Oncology. 131(4). 699–702.
5.
Chávez, Guadalupe, Machelle Wilson, Morgan Darrow, et al.. (2024). Intraoperative Peripheral Frozen Margin Assessment in Soft Tissue Sarcoma. Journal of Surgical Oncology. 131(4). 694–698.
6.
Canter, Robert J., et al.. (2024). Suppressive effects of obesity on NK cells: is it time to incorporate obesity as a clinical variable for NK cell-based cancer immunotherapy regimens?. Journal for ImmunoTherapy of Cancer. 12(3). e008443–e008443. 3 indexed citations
7.
Freeland, Jack, Edmond F. O’Donnell, Justin Langerman, et al.. (2024). Genetic Screen in a Preclinical Model of Sarcoma Development Defines Drivers and Therapeutic Vulnerabilities. Clinical Cancer Research. 30(21). 4957–4973. 1 indexed citations
8.
Harris, H., Sean J. Judge, Marshall Lammers, et al.. (2024). Preclinical evaluation and first-in-dog clinical trials of PBMC-expanded natural killer cells for adoptive immunotherapy in dogs with cancer. Journal for ImmunoTherapy of Cancer. 12(4). e007963–e007963. 4 indexed citations
9.
Khuat, Lam T., et al.. (2023). PD-1 signaling serves a dual role in suppressing T cell activation but also in protecting from activation-induced cell death. The Journal of Immunology. 210(Supplement_1). 226.11–226.11. 2 indexed citations
10.
Khuat, Lam T., Ziming Wang, Ethan G. Aguilar, et al.. (2023). Aging augments obesity-induced thymic involution and peripheral T cell exhaustion altering the “obesity paradox”. Frontiers in Immunology. 13. 1012016–1012016. 12 indexed citations
11.
Judge, Sean J., Morgan Darrow, Nikhil Joshi, et al.. (2023). Human soft tissue sarcomas harbor an intratumoral viral microbiome which is linked with natural killer cell infiltrate and prognosis. Journal for ImmunoTherapy of Cancer. 11(1). e004285–e004285. 18 indexed citations
12.
Le, Catherine T., Cordelia Dunai, Lam T. Khuat, et al.. (2023). Regulation of human and mouse bystander T cell activation responses by PD-1. JCI Insight. 8(18). 6 indexed citations
13.
Bateni, Cyrus, Janai R. Carr, Arta M. Monjazeb, et al.. (2023). Scrutinizing the use of contrasted chest CTs in extremity sarcoma staging and surveillance. Journal of Surgical Oncology. 129(3). 523–530.
14.
Aguilar, Ethan G., Cordelia Dunai, Sean J. Judge, et al.. (2021). Activation status dictates the function of unlicensed natural killer cells in mice and humans. Blood Advances. 5(20). 4219–4232. 2 indexed citations
15.
Khuat, Lam T., Cordelia Dunai, Shyam K. More, et al.. (2021). Increased efficacy of dual proinflammatory cytokine blockade on acute GVHD while maintaining GVT effects. Blood. 138(24). 2583–2588. 9 indexed citations
16.
Withers, Sita S., Katherine A. Skorupski, Daniel York, et al.. (2018). Association of macrophage and lymphocyte infiltration with outcome in canine osteosarcoma. Veterinary and Comparative Oncology. 17(1). 49–60. 37 indexed citations
17.
Monjazeb, Arta M., Michael S. Kent, Steven K. Grossenbacher, et al.. (2016). Blocking Indolamine-2,3-Dioxygenase Rebound Immune Suppression Boosts Antitumor Effects of Radio-Immunotherapy in Murine Models and Spontaneous Canine Malignancies. Clinical Cancer Research. 22(17). 4328–4340. 91 indexed citations
18.
Boutin, Robert D., et al.. (2016). Conservative management of desmoid tumors is safe and effective. Journal of Surgical Research. 205(1). 115–120. 20 indexed citations
19.
Brown, Erin G., et al.. (2014). Hospital Readmissions. Annals of Surgery. 260(4). 583–591. 39 indexed citations
20.
Canter, Robert J., Li-Xuan Qin, Robert G. Maki, et al.. (2008). A Synovial Sarcoma-Specific Preoperative Nomogram Supports a Survival Benefit to Ifosfamide-Based Chemotherapy and Improves Risk Stratification for Patients. Clinical Cancer Research. 14(24). 8191–8197. 133 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Roberto Stasi Breakdown of academic impact, for papers by K. Scott Baker Breakdown of academic impact, for papers by Marc E. Horowitz Breakdown of academic impact, for papers by Dominique Farge Breakdown of academic impact, for papers by Meenakshi Devidas Breakdown of academic impact, for papers by Celia M. Divino Breakdown of academic impact, for papers by Marc Riquet Breakdown of academic impact, for papers by Peter Chang Breakdown of academic impact, for papers by Jan Paul de Boer Breakdown of academic impact, for papers by Christina Peters
Rankless by CCL
2026